SCHEMBL6494917

SCHEMBL6494917

Cc1cc(C[S])c2ccccc2n1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.60
▸ NCF1 P14598 4/20 0.56
▸ CYP2C19 P33261 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ USP2 O75604 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ GALR3 O60755 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985541 0.85 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL8232676 0.82 CYP1A2 (0.62) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL1366357 0.82 CYP1A2 (0.62) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL5898542 0.81 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL994597 0.81 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL3921968 0.81 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL3964916 0.81 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL6494921 0.81 CYP1A2 (0.60) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL265139 0.81 NCF1 (0.61) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2
SCHEMBL18535317 0.79 CYP1A2 (0.58) CYP1A2NCF1CYP2C19KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884806-B2 Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-26 — — US disclosed
Send feedback